PLOS Global Public Health (Jan 2022)

The rise in antimicrobial resistance: An obscure issue in COVID-19 treatment.

  • Yogendra Shrestha,
  • Ravi Kurikempannadoddi Shivalingegowda,
  • Melkote Jyotiprakash Avinash,
  • Sharath Babu Hagalahalli Kenchegowda,
  • Jeet Bahadur Moktan,
  • Sreenivas Murthy Doddasamiah,
  • Ramesh Mahadev Tambat,
  • Deepanjali Girish Golshetty,
  • Vakkalagadda Siva Ganesh,
  • Rajesh Venkataraman

DOI
https://doi.org/10.1371/journal.pgph.0000641
Journal volume & issue
Vol. 2, no. 7
p. e0000641

Abstract

Read online

A saturated health care system with a lack of evidence-based antiviral medicine and ignorance of antimicrobial stewardship during pandemics has prompted clinicians to prescribe a broad-spectrum antibiotic more often. A prospective, cross-sectional study of COVID-infected patients was conducted to gain insight into antibiotic prescribing practices and their impact on antimicrobial resistance. The antibiotic susceptibility test was performed using the disc diffusion method. 318 patients met the study's inclusion criteria, with a mean age of 46 years and 55% (175) of them being males. Antibiotics were prescribed for 93.72% (209) of mild cases, 92.45% (49) of moderate cases, 96.15% (25) of severe cases, and 100% (16) of critical cases of COVID-19. A total of 95 samples were sent in for culture and antibiotic sensitivity testing, with 58.95% (56) confirming growth. The majority of the growth was found to contain E. coli (14). In 54.9% of cases, antibiotics with less than 50% sensitivity to curing bacterial infection were detected. In the study, we found that antibiotics were being used unnecessarily in excessive quantities and that more than half of the antibiotics were less sensitive to isolated bacteria.